Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial.

Lam, Garrett K; Hopoate-Sitake, Moana; Adair, C David; Buckalew, Vardaman M; Johnson, Donna D; Lewis, David F; Robinson, Christopher J; Saade, George R; Graves, Steven W

Lam, Garrett K; Hopoate-Sitake, Moana; Adair, C David; Buckalew, Vardaman M; Johnson, Donna D; Lewis, David F; Robinson, Christopher J; Saade, George R; Graves, Steven W.

Affiliation

Lam GK; Department of Obstetrics and Gynecology, University of Tennessee School of Medicine, Chattanooga, TN, USA.

Am J Obstet Gynecol ; 209(2): 119.e1-6, 2013 Aug.

Article in En | MEDLINE | ID: mdl-23583219

Subject(s)

Cardenolides/blood; Immunoglobulin Fab Fragments/therapeutic use; Pre-Eclampsia/drug therapy; Saponins/blood; Adult; Antihypertensive Agents/therapeutic use; Creatinine/blood; Double-Blind Method; Female; Humans; Infant, Newborn; Pre-Eclampsia/blood; Pregnancy

Key words

DEEP Trial; Digibind; creatinine clearance; intraventricular hemorrhage; pulmonary edema; sodium pump

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pre-Eclampsia / Saponins / Immunoglobulin Fab Fragments / Cardenolides Type of study: Clinical_trials Limits: Adult / Female / Humans / Newborn / Pregnancy Language: En Journal: Am J Obstet Gynecol Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google